CTTI Launches New Recommendations to Improve Qualification of Investigators

CTTI will release new recommendations that propose a new approach for investigator qualification during a public webinar on Thurs., Nov. 15. This approach goes beyond repetitive one-size-fits-all training and includes individual experience and protocol-specific preparation.

 

Current regulations from the U.S. Food and Drug Administration (FDA) require that sponsors and their delegates select qualified investigators. Good Clinical Practice (GCP) training is widely used as the industry standard for ensuring investigators are qualified, but there is little evidence that completion of GCP training alone sufficiently qualifies investigators and their delegates to conduct quality clinical trials.

 

To address this challenge, CTTI convened a team of experts and leaders across the clinical trials enterprise to develop new recommendations and resources that can help to implement a more efficient and effective qualification process and determine whether a site team is a good fit for a particular protocol. CTTI’s recommended approach recognizes previous training and experience, identifies gaps in knowledge and skills, and improves understanding of how to apply GCP principles to the conduct of clinical trials.

 

By implementing CTTI’s recommendations, stakeholders could improve the execution of study protocols and ultimately the overall quality of trials. The recommendations could also help create a culture of collaboration and provide ongoing support through formalized mentorship and knowledge-sharing platforms.

 

The webinar will begin at noon ET and will be led by Jimmy Bechtel of the Society for Clinical Research Sites (SCRS), Sabrina Comic-Savic of The Medicines Company, and Kate Haratonik of Genentech—a member of the Roche Group.

CTTI to Offer Insights on Investigator Qualification, Mobile Technologies, and Other Opportunities in Clinical Research at ACRP 2018

The ACRP 2018 education and networking event will feature three presentations from CTTI highlighting evidence-based strategies for enhancing clinical trial quality and efficiency. The event will take place in National Harbor, Md., from April 27-30.

On Sat., April 28, CTTI Executive Director Pamela Tenaerts will join leaders across the clinical trials enterprise to discuss collaborative initiatives to improve clinical research, including investigator qualification, quality by design, the use of mobile technologies, and more.

The following day, CTTI will share findings from its Investigator Qualification Project, which explores how best to ensure the efficient and effective qualification of site investigators and their delegates for the quality conduct of clinical trials. In a recent ACRP article, presenter Janette Panhuis of PHRI underscores the importance of CTTI’s work to move the clinical trials enterprise toward more meaningful investigator training.

On Mon., April 30, CTTI will discuss outcomes of in-depth interviews with investigators who have conducted both traditional clinical trials and studies using mobile technologies, providing insights on the advantages and disadvantages to be aware of when running a trial with mobile technology, budgetary and training needs, and other important factors for investigative site personnel to consider. Read more about CTTI’s MCT Stakeholder Perceptions Project.

We hope you will be able to join us at ACRP 2018. Please visit the CTTI Events page for more information about these and other upcoming CTTI presentations.

Presentation: Meet the Changemakers: Driving Clinical Research Quality Through Collaborative Leadership

Date & Time: Sat., April 28, 8:00 – 9:00 a.m.

Presenters: Pamela Tenaerts (CTTI), Patricia Leuchten (The Avoca Group), Douglas Peddicord (Association of Clinical Research Organizations), and Andy Lee (Merck)

Presentation: Defining Quality in Clinical Trial Conduct and Preparing Investigators for Success: Findings from CTTI’s Investigator Qualification Project

Date & Time: Sun., April 29, 11:30 a.m. – 12:30 p.m.

Presenters: Sabrina Comic-Savic (The Medicines Company), Bridget Foltz (FDA), Janette Panhuis (PHRI), and Diana Foster (ACRP)

Presentation: Investigator Perspectives and Insights on the Use of Mobile Tech in Clinical Trials: Findings from CTTI’s Mobile Clinical Trials Project
Date & Time: Mon., April 30, 9:30 – 10:30 a.m.

Presenters: Steve Morin (FDA) and Virginia Nido (Genentech, a member of the Roche Group)

CTTI Explores How to Prepare Qualified Investigators and their Delegates: Latest Expert Meeting Summary Now Available

Although good clinical practice (GCP) training has long been considered the industry standard for ensuring investigators are qualified for the high-quality conduct of clinical trials, little evidence has been collected to determine whether it actually provides the knowledge and skills to equip investigators and their delegates to conduct clinical trials.

To address this issue, CTTI convened an expert meeting in December 2017 to discuss action that can be taken to inform the efficient and effective qualification of site investigators and their delegates. The meeting (see one-page summary) included representatives from pharmaceutical companies, government, research sites, contract research organizations, patient representatives, and other groups.

Meeting participants collaborated to refine a draft framework defining characteristics synonymous with the quality conduct of clinical trials. They discussed the need to shift the focus from individual investigators to the entire study team and identified value in mentorship, just-in-time training, and peer-to-peer networks to support site personnel in their specific roles. In addition, participants probed how it may be possible to develop and deliver more patient-centric training, foster a culture of learning, and drive the evolution of investigator qualification to include more adult learning approaches and a focus on how to apply knowledge—not just recall it. Attendees also identified the need for a harmonized system to better help sponsors identify suitable sites without mandating specific training.

As a next step in its Investigator Qualification work, CTTI will develop recommendations and resources to improve the quality of trial conduct through optimized approaches to qualifying investigators and their delegates.

CTTI Shares New Insights on Early Enrollment, Barriers to Remote Clinical Trials, and Improving Investigator Trainings at PRIM&R Advancing Ethical Research Conference

CTTI will present findings during three sessions at the upcoming PRIM&R Advancing Ethical Research (AER) Conference.

On Mon., Nov. 6, CTTI will share data on stakeholder perceptions of early informed consent and enrollment in clinical trials. While early enrollment could improve the ability to conduct trials that evaluate the efficacy and safety of treatments for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP), questions remain about implementing it ethically and effectively. CTTI will share findings from its HABP/VABP Studies Project on the acceptability of an early informed consent approach for high-risk patients and essential information that should be shared with key stakeholders.

On Wed., Nov. 8, CTTI will discuss findings from its MCT Legal & Regulatory Project on actual and perceived barriers that may be preventing the widespread use of mobile technology in clinical trials. Presenters will explore potential challenges and opportunities of conducting clinical research remotely, and solicit input from clinical enterprise stakeholders on potential ethics implications. The project is part of CTTI’s Mobile Clinical Trials (MCT) Program.

In a separate session, CTTI will also present findings to date for its Investigator Qualification project and Investigator Community recommendations. The presenter will examine whether current GCP training methods actually provide the knowledge and skills necessary to conduct quality clinical trials. Further, he will detail recently released recommendations that aim to strengthen the clinical trials investigator and study team community through better training and other approaches.

We hope you will join us in San Antonio, Texas, Nov. 5-8 as we share new insights into these noteworthy clinical trials topics.

Presentation: Stakeholder Perceptions on Early Informed Consent for Clinical Trials
Date & Time: Mon., Nov. 6, 3:30 – 4:45 p.m.
Presenters: Amy Corneli (CTTI) and Thomas Holland (Duke University)

Presentation: Clinical Trials Transformation Initiative (CTTI) Mobile Clinical Trials, Legal, and Regulatory Project
Date & Time: Wed., Nov. 8, 11:15 a.m. – 12:30 p.m.
Presenters: David Babaian (Kinetiq), Linda Coleman (Yale University), and Jan Hewett (FDA

Presentation: Beyond Good Clinical Practice (GCP) Training: Expanding the Tool Set for Preparing Investigators
Date & Time: Wed., Nov. 8, 11:15 a.m. – 12:30 p.m.
Presenters: Gerrit Hamre (CTTI)

CTTI Launches New Project to Improve Process for Qualifying Investigators to Conduct Clinical Trials

Ineffective or redundant training for investigators wastes time, resources, and does not prepare investigators for the quality conduct of clinical trials. Rather than accepting GCP training as the default solution for qualifying investigators to conduct clinical trials, CTTI is collecting evidence to determine effective and efficient approaches.

While good clinical practice (GCP) training has become the standard for qualifying investigators to conduct clinical trials, little evidence has been collected to determine whether this training is providing the necessary knowledge and skills. CTTI’s new Investigator Qualification Project will evaluate current approaches to investigator qualification, including GCP training, and issue recommendations on effective and efficient methods for investigators to become qualifiehttps://ctti-clinicaltrials.org/projects/investigator-qualification-gcp-trainingd to conduct clinical trials. Investigators, research sponsors, and trial participants are all expected to benefit from an improved investigator qualification process.

CTTI previously released recommendations to address the issue of staff being required to take GCP training before each clinical trial, often multiple times each year. The Investigator Qualification Project is an extension of this work and will focus on the quality of training. CTTI will gather evidence to identify gaps and redundancies in current training, as well as suggest other ways of ensuring that investigators are qualified for the quality conduct of clinical trials.

New Publication Points to Solutions to Reduce Unnecessary Burden on Clinical Trial Sites

Time and energy are valuable resources to clinical investigators. CTTI’s recent publication, “Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency,” provides evidence that redundant Good Clinical Practice (GCP) training places an unnecessary burden on investigators. Investigators should be relieved of the burden of repetitive training so they can focus on what matters most: protecting the rights, integrity, and confidentiality of clinical trial participants and assuring the credibility and accuracy of data and reported results. The authors offer suggestions to increase applied learning, focus on relevant trial information, and tailor training for specific job functions.

CTTI’s GCP Training Project team conducted a literature review to inform the project on current practices in the implementation of GCP training and analyzed sample GCP training programs. The findings were discussed by a multi-stakeholder group of experts who helped the team to develop official recommendations that were released in 2015. The recommendations include the 13 minimum essential elements for a training program, training frequency and format, and evidence of successful completion of training.

The paper was published in Therapeutic Innovation & Regulatory Science (TIRS).